October 2019 FDA Recall Isotretinoin by Amneal Pharmaceuticals, Inc.
D-0321-2020 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Amneal Pharmaceuticals, Inc. on October 16, 2019 for the product Isotretinoin. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed in Recalled product was distributed to retailers and wholesalers who may have further distribute the product. and the recall is currently terminated.

Recall Number: D-0321-2020

Reason for Recall
Failed Impurities/Degradation Specifications: Tretinoin levels slightly above specification limits.
Initiated
10-16-2019
Reported
11-20-2019
Quantity
2460 cartons/3 blister cards/10 capsules each

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Amneal Pharmaceuticals, Inc.
Recalled product was distributed to retailers and wholesalers who may have further distribute the product.
Isotretinoin Capsules, USP 10 mg. Rx Only, 3 Prescription Blister Packs of 10- Capsules Each (30 Capsules)-. Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC 69238-1174-3

Batch or Lot Expiration Information

Batch# Batch Numbers: BL10917, BL11017, BL11117, Exp. date 11/2019